ucb-usa.com
Get leads like Ucb-usa — and thousands more
Build targeted lists by tech stack, traffic, and more
UCB-USA.com: Pharma's Quiet Giant
A $24M revenue site for a $1.5B biopharma giant. The numbers don't add up... or do they?
UCB-USA.com isn't a DTC startup—it's the digital front door for a biopharma titan moving $24.1M through a 120-person US operation. But the real story isn't the revenue; it's the traffic split that screams 'brand moat'.
"46% direct traffic isn't a marketing metric—it's a trust signal that money can't buy."
The Traffic Paradox
With just 22,898 monthly visits, UCB-USA.com looks like a ghost town. But 46% direct traffic (37% organic) reveals a precision instrument, not a volume play. This isn't a lead gen funnel—it's a controlled access point for HCPs, patients, and partners who already know the brand. The $1.5B funding backdrop suggests this is a regulatory and trust layer, not a growth engine.
The Keyword Moat
Search data exposes the real strategy: 'UCB' at 47K monthly volume dominates, while 'UCB rare disease' (70 volume) and 'jenny murase' (210 volume) reveal a surgical focus on niche medical communities. They don't chase broad pharma terms—they own the conversations that matter to specialists. This is how you dominate without shouting.
The tech stack tells a story of compliance-first architecture. OneTrust for privacy, Varnish for caching, jQuery and Bootstrap for stability over flash. This isn't a site built for conversion funnels—it's built for HIPAA-level scrutiny and uptime guarantees. The LinkedIn Insight Tag is the only growth signal, suggesting B2B relationship tracking over consumer acquisition.
- Revenue per employee: $200K—lean but likely undercounted (revenue attribution is complex in pharma)
- Funding-to-revenue ratio: 62x—this is a pipeline play, not a profitability story
- Traffic quality over quantity: 22K visits with 86% from 'undefined' geo (likely US + EU privacy shielding)
- Rare disease focus: Keywords indicate high-value, low-volume patient populations
The Unsexy Unicorn
UCB-USA.com proves that in biopharma, the best growth strategy is being indispensable to the right 22,000 people.
What tech stack does Ucb-usa use?
How much traffic does Ucb-usa get?
Traffic & Engagement
Traffic Sources
Where is Ucb-usa's audience located?
What keywords does Ucb-usa rank for?
5 keywordsWhat is Ucb-usa's revenue?
Who works at Ucb-usa?
Loading leads...
What do customers think of Ucb-usa?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Ucb-usa
What is Ucb-usa's Revenue?
How fast is Ucb-usa growing?
What technologies does Ucb-usa use?
Who are Ucb-usa's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
Export ucb-usa.com Data
Download the complete tech stack, analytics, leads, and company data for ucb-usa.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About ucb-usa.com
Company Overview
Technology Stack
ucb-usa.com uses 13 technologies across their website including Vimeo, YouTube Embed, HSTS, Varnish, and more.
Video
Vimeo, YouTube Embed
Security
HSTS
Caching
Varnish
Privacy & Consent
OneTrust
Advertising
LinkedIn Insight Tag
Analytics & Marketing
Google Tag Manager, Google Analytics
Traffic & Audience
ucb-usa.com receives approximately 22.9K monthly visitors and ranks #1,262,203 globally. The website has a bounce rate of 59% with visitors viewing an average of 1.7 pages per visit. Users spend an average of 0:42 on the site.
The majority of ucb-usa.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is ucb-usa.com?
What technologies does ucb-usa.com use?
How popular is ucb-usa.com?
Related Searches
This page provides publicly available information about ucb-usa.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit ucb-usa.com directly at https://ucb-usa.com.